Clinical Trials
2 trialsNCT01402089 2016-02-02
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients
Cantonal Hospital of St. Gallen
Phase 4 Completed
NCT00777504 2011-09-16
Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors
Radboud University Medical Center
Phase 4 Unknown